OCT4: Biological functions and clinical applications marker of germ cell neoplasia

Liang Cheng, M. T. Sung, P. Cossu-Rocca, T. D. Jones, G. T. MacLennan, J. De Jong, A. Lopez-Beltran, R. Montironi, L. H J Looijenga

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an over-all good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/ germinoma and embryonal carcinoma. The development of commercially available OCT4-specific antibodies suitable for immunohistochemistry on paraffin-embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non-seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre-invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalJournal of Pathology
Volume211
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Germ Cell and Embryonal Neoplasms
Germ Cells
Biomarkers
Neoplasms
Embryonal Carcinoma
Octamer Transcription Factor-3
Differential Diagnosis
Gonadoblastoma
Immunohistochemistry
Dysgerminoma
Germinoma
Seminoma
Gonads
Cellular Structures
Embryonic Stem Cells
Paraffin
Maintenance
Antibodies

Keywords

  • Embryonal carcinoma
  • Germ cell tumuor
  • Oct3/4
  • POU5F1
  • Seminoma
  • Stem cell biomarkers
  • Testis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cheng, L., Sung, M. T., Cossu-Rocca, P., Jones, T. D., MacLennan, G. T., De Jong, J., ... Looijenga, L. H. J. (2007). OCT4: Biological functions and clinical applications marker of germ cell neoplasia. Journal of Pathology, 211(1), 1-9. https://doi.org/10.1002/path.2105

OCT4 : Biological functions and clinical applications marker of germ cell neoplasia. / Cheng, Liang; Sung, M. T.; Cossu-Rocca, P.; Jones, T. D.; MacLennan, G. T.; De Jong, J.; Lopez-Beltran, A.; Montironi, R.; Looijenga, L. H J.

In: Journal of Pathology, Vol. 211, No. 1, 01.2007, p. 1-9.

Research output: Contribution to journalArticle

Cheng, L, Sung, MT, Cossu-Rocca, P, Jones, TD, MacLennan, GT, De Jong, J, Lopez-Beltran, A, Montironi, R & Looijenga, LHJ 2007, 'OCT4: Biological functions and clinical applications marker of germ cell neoplasia', Journal of Pathology, vol. 211, no. 1, pp. 1-9. https://doi.org/10.1002/path.2105
Cheng, Liang ; Sung, M. T. ; Cossu-Rocca, P. ; Jones, T. D. ; MacLennan, G. T. ; De Jong, J. ; Lopez-Beltran, A. ; Montironi, R. ; Looijenga, L. H J. / OCT4 : Biological functions and clinical applications marker of germ cell neoplasia. In: Journal of Pathology. 2007 ; Vol. 211, No. 1. pp. 1-9.
@article{fba4201e03ae4c198bae3195eb4b09a4,
title = "OCT4: Biological functions and clinical applications marker of germ cell neoplasia",
abstract = "Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an over-all good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/ germinoma and embryonal carcinoma. The development of commercially available OCT4-specific antibodies suitable for immunohistochemistry on paraffin-embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non-seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre-invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs.",
keywords = "Embryonal carcinoma, Germ cell tumuor, Oct3/4, POU5F1, Seminoma, Stem cell biomarkers, Testis",
author = "Liang Cheng and Sung, {M. T.} and P. Cossu-Rocca and Jones, {T. D.} and MacLennan, {G. T.} and {De Jong}, J. and A. Lopez-Beltran and R. Montironi and Looijenga, {L. H J}",
year = "2007",
month = "1",
doi = "10.1002/path.2105",
language = "English",
volume = "211",
pages = "1--9",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - OCT4

T2 - Biological functions and clinical applications marker of germ cell neoplasia

AU - Cheng, Liang

AU - Sung, M. T.

AU - Cossu-Rocca, P.

AU - Jones, T. D.

AU - MacLennan, G. T.

AU - De Jong, J.

AU - Lopez-Beltran, A.

AU - Montironi, R.

AU - Looijenga, L. H J

PY - 2007/1

Y1 - 2007/1

N2 - Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an over-all good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/ germinoma and embryonal carcinoma. The development of commercially available OCT4-specific antibodies suitable for immunohistochemistry on paraffin-embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non-seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre-invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs.

AB - Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an over-all good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/ germinoma and embryonal carcinoma. The development of commercially available OCT4-specific antibodies suitable for immunohistochemistry on paraffin-embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non-seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre-invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs.

KW - Embryonal carcinoma

KW - Germ cell tumuor

KW - Oct3/4

KW - POU5F1

KW - Seminoma

KW - Stem cell biomarkers

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=33846228391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846228391&partnerID=8YFLogxK

U2 - 10.1002/path.2105

DO - 10.1002/path.2105

M3 - Article

C2 - 17117392

AN - SCOPUS:33846228391

VL - 211

SP - 1

EP - 9

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 1

ER -